<DOC>
	<DOCNO>NCT01689753</DOCNO>
	<brief_summary>The aim trial ass whether use TEGO connector able reduce incidence composite endpoint TCC-related dysfunction ( TCC-D ) TCC-related bacteremia ( TCC-B ) chronic hemodialysis ( HD ) patient carry TEGO® connector v control receive trisodium citrate 46.7 % .</brief_summary>
	<brief_title>Effect TEGO Connector Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia</brief_title>
	<detailed_description>The TEGO® connector ( ICU Medical , www.icumed.com ) close positive pressure system , flush 0.9 % sodium chloride attach hubs TCC . As recommended producer , TEGO® remain 3 consecutive HD session change every week . By constitute mechanical barrier , could interest alternative reduce intraluminal contamination risk TCC-B . The TEGO® connector suppose provide automatic positive displacement fluid end TCC flush . This positive pressure could prevent reflux blood TCC lumen , possibly result TCC-D. As impact TEGO® connector TCC-D TCC-B never study , conduct randomize control study center compare anti-thrombotic anti-infectious efficacy TEGO® connector trisodium citrate 46.7 % ( Citralock® , Dirinco , www.citra-lock.com ) . The global cost procedure also evaluate .</detailed_description>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Adult HD patient , prevalent incident , carry tunnel cuffed catheter Tunneled cuffed catheter provide mean blood flow superior 250 ml/min Patients sign informed consent Mature arteriovenous fistula Episode TCCrelated bacteremia 1 week randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Renal dialyse</keyword>
	<keyword>Catheter , indwell</keyword>
	<keyword>Catheter-related infection</keyword>
</DOC>